Journal Abbreviation: CANCER RES Journal ISSN: 0008-5472 YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)12.5253122978 202211.2-141481 202113.312-161957 202012.701453159236 20199.727536135753 20188.378555130932 20179.130632139291 20169.122648139655 ...
Year Impact Factor (IF) Total Articles Total Cites 2023 (2024 update) 3.4 - - 2022 3.8 - 46702 2021 4.638 - 46148 2020 4.430 1196 41517 2019 3.150 1240 30109 2018 2.933 1282 25843 2017 3.288 889 24272 2016 3.288 891 21145 2015 3.265 1019 17676 2014 3.362 981 15227 2013 3.319 616 ...
• Epigenomics and Precision Medicine • Next-Generation Therapeutics For any kind of queries, please contact us atcontact@fortunejournals.comorcontactfortunejournals@gmail.com *Impact Factor mentioned on our website is provided byCosmos Foundation, Germany. ...
Functional characterization of genetic alterations is a prerequisite for pancreatic cancer precision medicine. Here, using in vivo CRISPR screens, the authors integrate human cancer genomics and mouse models, identifying that loss of USP15 or SCAF1 accelerates tumor development and leads to reduced infla...
09 May 2022|Open Access Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results In an interim analysis of a phase 1 trial, CAR T cells specific for Claudin18.2, a tight junction protein isoform highly expressed on gastrointestinal tract tumors, were well-tolera...
ManagementApplication of Nuclear Medicine in Cancer Diagnosis and TreatmentBreaking Barriers in Cancer Care: Selected Papers from Capital Health Cancer Center Second Annual Conference 2022Cancer Disease: Beyond the Border of TherapyCancer in GestationCancer Screening, Diagnosis and Theragnosis Using Artificial...
actual gains in the practice of cancerdiagnosisand treatment, with notable progress towardpersonalized medicine, in which therapy is tailored to individuals according to biologicalanomaliesunique to their disease. Personalized medicine is considered a promising area of progress yet for modern cancer therapy...
Medicine 2020, 99, e19834. [Google Scholar] [CrossRef] [PubMed] Götze, H.; Taubenheim, S.; Dietz, A.; Lordick, F.; Mehnert, A. Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics. J. Cancer ...
Oncology has been main precision medicine efforts largely due to our huge understanding of the function of genetic mutations within the development and development of cancer. Precision medication allows to method detection, prognosis and treatment in an in-depth way to decide how a most cancers ...
Edited byLogan Spector University of Minnesota, Minneapolis, Minnesota, USA,Philip Lupo Baylor College of Medicine, Houston, Texas, USA 13 June 2023 Tobacco Cessation after Cancer Edited byJustin Smith,Kayo Togawa,Carolyn Dresler,Feras Hawari,Zarihah M. Zain,Bernard Stewart,Graham W. Warren,Freddy...